BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1620549)

  • 1. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
    Milne DM; Palmer RH; Campbell DG; Meek DW
    Oncogene; 1992 Jul; 7(7):1361-9. PubMed ID: 1620549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
    Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate.
    Milne DM; McKendrick L; Jardine LJ; Deacon E; Lord JM; Meek DW
    Oncogene; 1996 Jul; 13(1):205-11. PubMed ID: 8700548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of casein kinase II with immunopurified p53.
    Herrmann CP; Kraiss S; Montenarh M
    Oncogene; 1991 May; 6(5):877-84. PubMed ID: 2052362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for CKI and CKII at the cell surface.
    Walter J; Kinzel V; Kübler D
    Cell Mol Biol Res; 1994; 40(5-6):473-80. PubMed ID: 7735321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition.
    Longenecker KL; Roach PJ; Hurley TD
    J Mol Biol; 1996 Apr; 257(3):618-31. PubMed ID: 8648628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
    Hu MC; Qiu WR; Wang YP
    Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage.
    Knippschild U; Milne D; Campbell L; Meek D
    Oncogene; 1996 Oct; 13(7):1387-93. PubMed ID: 8875976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
    Meek DW; Simon S; Kikkawa U; Eckhart W
    EMBO J; 1990 Oct; 9(10):3253-60. PubMed ID: 2145148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo.
    Jamal S; Ziff EB
    Oncogene; 1995 Jun; 10(11):2095-101. PubMed ID: 7784054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinases CKI and CKII are implicated in modification of ribosomal proteins of the yeast Trichosporon cutaneum.
    Wojda I; Cytryńska M; Frajnt M; Jakubowicz T
    Acta Biochim Pol; 2002; 49(4):947-57. PubMed ID: 12545201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
    Firzlaff JM; Galloway DA; Eisenman RN; Lüscher B
    New Biol; 1989 Oct; 1(1):44-53. PubMed ID: 2562189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
    Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
    Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two nonmuscle myosin II heavy chain isoforms expressed in rabbit brains: filament forming properties, the effects of phosphorylation by protein kinase C and casein kinase II, and location of the phosphorylation sites.
    Murakami N; Chauhan VP; Elzinga M
    Biochemistry; 1998 Feb; 37(7):1989-2003. PubMed ID: 9485326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms.
    Walter J; Grünberg J; Schindzielorz A; Haass C
    Biochemistry; 1998 Apr; 37(17):5961-7. PubMed ID: 9558331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine neurofilament-enriched preparations contain kinase activity similar to casein kinase I--neurofilament phosphorylation by casein kinase I (CKI).
    Link WT; Dosemeci A; Floyd CC; Pant HC
    Neurosci Lett; 1993 Mar; 151(1):89-93. PubMed ID: 8385762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.